Regulated induced proximity targeting chimeras-RIPTACs-A heterobifunctional small molecule strategy for cancer selective therapies.

Autor: Raina K; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Forbes CD; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Stronk R; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Rappi JP Jr; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Eastman KJ; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Zaware N; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Yu X; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Li H; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Bhardwaj A; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Gerritz SW; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Forgione M; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Hundt A; Halda Therapeutics OpCo Inc, New Haven, CT, USA., King MP; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Posner ZM; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Correia AD; Halda Therapeutics OpCo Inc, New Haven, CT, USA., McGovern A; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Puleo DE; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Chenard R; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Mousseau JJ; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Vergara JI; Department of Molecular, Cellular, & Developmental Biology, Yale University, New Haven, CT, USA., Garvin E; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Macaluso J; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Martin M; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Bassoli K; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Jones K; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Garcia M; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Howard K; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Yaggi M; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Smith LM; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Chen JM; Halda Therapeutics OpCo Inc, New Haven, CT, USA., Mayfield AB; Department of Molecular, Cellular, & Developmental Biology, Yale University, New Haven, CT, USA., De Leon CA; Department of Molecular, Cellular, & Developmental Biology, Yale University, New Haven, CT, USA., Hines J; Department of Molecular, Cellular, & Developmental Biology, Yale University, New Haven, CT, USA., Kayser-Bricker KJ; Halda Therapeutics OpCo Inc, New Haven, CT, USA. Electronic address: kat.kayser-bricker@haldathera.com., Crews CM; Department of Molecular, Cellular, & Developmental Biology, Yale University, New Haven, CT, USA; Department of Pharmacology, Yale University, New Haven, CT, USA; Department of Chemistry, Yale University, New Haven, CT, USA. Electronic address: craig.crews@yale.edu.

Publikováno v: Cell chemical biology [Cell Chem Biol] 2024 Aug 15; Vol. 31 (8), pp. 1490-1502.e42. Date of Electronic Publication: 2024 Aug 07.

Therapeutic Approaches to Targeting Androgen Receptor Splice Variants.

Autor: Daniels, Violet A.¹ (AUTHOR) vdaniel5@jhmi.edu, Luo, Jun^1,2 (AUTHOR) jluo2@jhmi.edu, Paller, Channing J.² (AUTHOR) cpaller1@jhmi.edu, Kanayama, Mayuko¹ (AUTHOR) cpaller1@jhmi.edu

Publikováno v: Cells (2073-4409). Jan2024, Vol. 13 Issue 1, p104. 17p.

Ir. J.H. van den Broek: Projekten uit de periode 1928-1948

Autor: Stronk, R., Fosso, M., Meeuwissen, J., Stroink, R.

Publikováno v: None

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::8937eb9521a71327e64a4addf040f073
http://resolver.tudelft.nl/uuid:0cb6b550-a009-4805-ae43-d6f59c7b1bcb

POLSKA BIBLIOGRAFIA WYBORCZO-REFERENDALNA ZA ROK 20211. (Polish)

Autor: Frydrych-Depka, Anna, Zych, Radosław, Hoffman, Martyna

Publikováno v: Studia Wyborcze; 2022, Vol. 34, p143-168, 26p

The Role of Beta Receptor Agonist Therapy in Asthma Mortality

Autor: Richard Beasley, Neil E. Pearce

First published in 1993, the Role of Beta Receptor Agonist Therapy in Asthma Mortality provides the first comprehensive review of the role of beta-receptor agonist drug therapy and asthma mortality. The book includes sections on the epidemiological a